Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-21-015019

Options or other derivatives

  • COO acquired 0 shares (grant or award)
  • COO acquired 0 shares (option exercise)
  • COO acquired 38,473 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Horowitz Bruce COO 2021-06-17 Grant or award · 8% Secured Convertible Promissory Notes due 2021 +0 D
Horowitz Bruce COO 2021-06-20 Option exercise · 8% Secured Convertible Promissory Notes due 2021 −0 0 D
Horowitz Bruce COO 2021-06-20 Option exercise · Series D-1 Convertible Preferred Stock +38,473 38,473 D
Loading xslF345X03/ownership.xml…